Obesity and Hypertension-Induced Restrictive Cardiomyopathy: A Harbinger of Things to Come

Hypertension

Volumn 43, Issue 5, 2004, Pages 911-917

  Pilz, Bernhard ^a   Bräsen, Jan Hinrich ^b   Schneider, Wolfgang ^b   Luft, Friedrich C ^a,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Helios Klinikum   (Germany)

^c FRANZ VOLHARD CLINIC   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CORONARY ARTERY BLOOD FLOW; DISEASE ASSOCIATION; FEMALE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE OVERLOAD; HUMAN; HYPERTENSION; OBESITY; PERICARDIAL EFFUSION; PRIORITY JOURNAL; RESTRICTIVE CARDIOMYOPATHY;

AGED; ANIMALS; CARDIOMYOPATHY, RESTRICTIVE; DEATH, SUDDEN; DIASTOLE; DISEASE PROGRESSION; EDEMA; FATAL OUTCOME; FEMALE; HEART CATHETERIZATION; HUMANS; HYPERTENSION; KIDNEY; OBESITY; PERICARDIOCENTESIS; PERITONEAL DIALYSIS; RATS; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 2342523472     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000126439.64838.b9     Document Type: Article

References (34)

1. Parmley WW. Pathophysiology and current therapy of congestive heart failure. J Am Coll Cardiol. 1989;13:771-785.
2. Narula J, Haider N, Virmani R, DiSavlo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw BA. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996;335:1182-1189.
3. Katz AM. The cardiomyopathy of overload: an unnatural growth response in the hypertrophied heart. Ann Intern Med. 1994;121:363-371.
4. Pascual M, Pascual DA, Soria F, Vincente T, Hernandez AM, Tebar FJ, Valdes M. Effects of isolated obesity on systolic and diastolic left ventricular function. Heart. 2003;89:1152-1156.
5. Carvounis CP, Nisar S, Guro-Razuman S. Significance of fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int. 2003;62:2223-2229.
6. Soler-Soler J, Sagrista-Sauleda J, Permanyer-Miralda G. Management of pericardial effusion. Heart. 2001;86:235-240.
7. Hoit BD. Management of effusive and constrictive pericardial heart disease. Circulation. 2002;105:2939-2942.
8. Angeja BG, Grossman W. Evaluation and management of diastolic heart failure. Circulation. 2003;107:659-663.
9. Matsumoto A, Hirata Y, Momomura S, Suzuki E, Yokoyama I, Sata M, Ohtani Y, Serizawa T. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. Am Heart J. 1995;129:139-145.
10. Gandhi SK, Powers JC, Nomeir A, Fowle K, Kitzman DW, Rankin KM, Little WC. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med. 2001;344:17.
11. Vasan R, Benjamin E, Levy D. Prevalence, clinical features, and prognosis of diastolic heart failure: an epidemiological perspective. J Am Coll Cardiol. 1995;26:1565-1574.
12. Pernenkil R, Vinson J, Shah A, Beckham V, Wittenberg C, Rich M. Course and prognosis in patients > or =70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction. Am J Cardiol. 1997;79:216-219.
13. Smith GL, Masoudi FA, Vaccarino V, Radford MJ, Krumholz HM. Outcomes in heart failure patients with preserved ejection fraction. J Am Coll Cardiol. 2003;41:1510-1518.
14. Zile MR. Heart failure with preserved ejection fraction: is this diastolic heart failure? J Am Coll Cardiol. 2003;41:1519-1522.
15. Pfeffer MA, Pfeffer JM, Frohlich ED. Pumping ability of the hypertrophying left ventricle of the spontaneously hypertensive rat. Circ Res. 1976;38:423-429.
16. Pfeffer JM, Pfeffer MA, Fishbein MC, Frohlich ED. Cardiac function and morphology with aging in the spontaneously hypertensive rat. Am J Physiol. 1979;237:H461-H468.
17. Szatkowski ML, Westfall MV, Gomez CA, Wahr PA, Michele DE, DelloRusso C, Turner II, Hong KE, Albayya FP, Metzger JM. In vivo acceleration of heart relaxation performance by parvalbumin gene delivery. J Clin Invest. 2001;107:191-198.
18. Kawaguchi M, Hay I, Fetics B, Kass DA. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation. 2003;107:714-720.
19. Burkhoff D, Maurer S, Packer M. Heart failure with a normal ejection fraction: is it really a disorder of diastolic function? Circulation. 2003;107:656-658.
20. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003;362:777-781.
21. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk. The Framingham experience. Arch Intern Med. 2002;162:1867-1872.
22. Grassi G, Seravalle G, Quarti-Trevano F, Dell'Oro R, Bolla G, Mancia G. Effects of hypertension and obesity on the sympathetic activation of heart failure patients. Hypertension. 2003;42:873-877.
23. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA. 2003;290:1906-1914.
24. Horwich TB, Fonarow GC. The impact of obesity on survival in patients with heart failure. Heart Fail Monit. 2002;3:8-14.
25. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol. 2003;14:561-566.
26. Engeli S, Feldpausch M, Gorzelniak K, Hartwig F, Heintze U, Janke J, Mohlig M, Pfeiffer AF, Luft FC, Sharma AM. Association between adiponectin and mediators of inflammation in obese women. Diabetes. 2003;52:942-947.
27. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796-1808.
28. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross IS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821-1830.
29. Steffen C. The men behind the eponym: Frederick Parkes Weber and Henry A. Christian: Weber-Christian disease. Am J Dermatopathol. 2002;24:514-517.
30. Von Haehling S, Jankowska EA, Anker SD. Tumour necrosis factor-alpha and the failing heart: pathophysiology and therapeutic implications. Basic Res Cardiol. 2004;99:18-28.
31. Mehrotra R, Khanna R. Peritoneal ultrafiltration for chronic congestive heart failure: rationale, evidence and future. Cardiology. 2001;96:177-182.
32. Dwyer TM, Banks SA, Alonso-Galicia M, Cockrell K, Carroll JF, Bigler SA, Hall JE. Distribution of renal medullary hyaluronan in lean and obese rabbits. Kidney Int. 2000;58:721-729.
33. Lemley DE, Ferrans VJ, Fox LM, Satler L, Cupps TR. Cardiac manifestations of Weber-Christian disease: report and review of the literature. J Rheumatol. 1991;18:756-760.
34. Hall JE. The kidney, hypertension, and obesity. Hypertension. 2003;41:625-633.